Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07224828Phase 3Completed
Phase 3, randomised, triple-blind trial in dental plaque and gingivitis (3 arms), sponsored by Colgate-Palmolive. Primary endpoints: Löe and Silness Gingival Index at 12 weeks and Rustogi Modification of the Navy Plaque Index at 12 weeks. Started Oct 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07224828.